V. K. Panthi, S. K. Jha, R. Pangeni, and K. R. Paudel, “Formulation and Development of Adapalene Topical Nanohydrogel Using Different Surfactants and Cosurfactants for Antiacne Activity: In Vitro and Ex Vivo Evaluation,” J. Nanomater. vol. 2022;2022, https://doi.org/10.1155/2022/6889293.

P. Kesharwani, K. Jain, and N. K. Jain, “Dendrimer as nanocarrier for drug delivery,”  2014. https://doi.org/10.1016/j.progpolymsci.2013.07.005.

P. Kesharwani and A. K. Iyer, “Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery,” May 01, 2015, Elsevier Ltd. https://doi.org/10.1016/j.drudis.2014.12.012.

P. Kesharwani et al., “PAMAM dendrimers as promising nanocarriers for RNAi therapeutics,” 2015, Elsevier. https://doi.org/10.1016/j.mattod.2015.06.003.

Kesharwani P, Tekade RK, Gajbhiye V, Jain K, Jain NK. Cancer targeting potential of some ligand-anchored poly(propylene imine) dendrimers: A comparison. Nanomedicine Nanotechnol Biol Med. 2011;7(3):295–304. https://doi.org/10.1016/j.nano.2010.10.010.

Article  CAS  Google Scholar 

Kim SA, et al. Oral Cancer Immunotherapy through a Simvastatin-Loaded Colloidal Dispersion System for the Generation of Sustained Antitumor Immunity. Adv Ther. 2021;4(8):2100025. https://doi.org/10.1002/ADTP.202100025.

Article  CAS  Google Scholar 

P. Kesharwani, R. K. Tekade, and N. K. Jain, “Generation dependent safety and efficacy of folic acid conjugated dendrimer based anticancer drug formulations,” Pharm. Res., vol. 32, no. 4, 2015, https://doi.org/10.1007/s11095-014-1549-2.

P. Kesharwani, H. Choudhury, J. G. Meher, M. Pandey, and B. Gorain, “Dendrimer-entrapped gold nanoparticles as promising nanocarriers for anticancer therapeutics and imaging,” Jun. 01, 2019, Elsevier Ltd. https://doi.org/10.1016/j.pmatsci.2019.03.003.

V. Mishra and P. Kesharwani, “Dendrimer technologies for brain tumor,” Drug Discov. Today, vol. 21, no. 5, 2016, https://doi.org/10.1016/j.drudis.2016.02.006.

Singh V, Kesharwani P. Recent advances in microneedles-based drug delivery device in the diagnosis and treatment of cancer. J Controlled Release. 2021;338:394–409. https://doi.org/10.1016/J.JCONREL.2021.08.054.

Article  CAS  Google Scholar 

J. U. Choi et al., “Modulating tumor immunity by metronomic dosing of oxaliplatin incorporated in multiple oral nanoemulsion,” J Control Release Off J Control. Release Soc., vol. 322, pp. 13–30, Jun. 2020, https://doi.org/10.1016/J.JCONREL.2020.03.012.

M. Imran et al., “Overcoming Multidrug Resistance of Antibiotics via Nanodelivery Systems,” Pharm. 2022 Vol 14 Page 586, vol. 14, no. 3, p. 586, Mar. 2022, https://doi.org/10.3390/PHARMACEUTICS14030586.

Kesharwani P, Gothwal A, Iyer AK, Jain K, Chourasia MK, Gupta U. Dendrimer nanohybrid carrier systems: an expanding horizon for targeted drug and gene delivery. Drug Discov Today. 2018;23(2):300–14. https://doi.org/10.1016/j.drudis.2017.06.009.

Article  CAS  PubMed  Google Scholar 

Surekha B, Kommana NS, Dubey SK, Kumar AVP, Shukla R, Kesharwani P. PAMAM dendrimer as a talented multifunctional biomimetic nanocarrier for cancer diagnosis and therapy. Colloids Surf B Biointerfaces. 2021;204:111837. https://doi.org/10.1016/j.colsurfb.2021.111837.

Article  CAS  PubMed  Google Scholar 

Singh V, Sahebkar A, Kesharwani P. Poly (propylene imine) dendrimer as an emerging polymeric nanocarrier for anticancer drug and gene delivery. Eur Polym J. 2021;158:110683. https://doi.org/10.1016/J.EURPOLYMJ.2021.110683.

Article  CAS  Google Scholar 

Kesharwani P, Tekade RK, Jain NK. Formulation development and in vitro-in vivo assessment of the fourth-generation PPI dendrimer as a cancer-targeting vector. Nanomed. 2014;9(15):2291–308.

Article  CAS  Google Scholar 

Kesharwani P, Gajbhiye V, Tekade RK, Jain NK. Evaluation of dendrimer safety and efficacy through cell line studies. Curr Drug Targets. 2011;12(10):1478–97.

Article  CAS  PubMed  Google Scholar 

Pangeni R, et al. Improvements in the Oral Absorption and Anticancer Efficacy of an Oxaliplatin-Loaded Solid Formulation: Pharmacokinetic Properties in Rats and Nonhuman Primates and the Effects of Oral Metronomic Dosing on Colorectal Cancer. Int J Nanomedicine. 2020;15:7719–43. https://doi.org/10.2147/IJN.S267424.

Article  CAS  PubMed  PubMed Central  Google Scholar 

R. Pangeni, S. Kang, S. K. Jha, L. Subedi, and J. W. Park, “Intestinal membrane transporter-mediated approaches to improve oral drug delivery,” J Pharm Investig. 2021 512, vol. 51, no. 2, pp. 137–158, Feb. 2021, https://doi.org/10.1007/S40005-021-00515-1.

Jee JP, Pangeni R, Jha SK, Byun Y, Park JW. Preparation and in vivo evaluation of a topical hydrogel system incorporating highly skin-permeable growth factors, quercetin, and oxygen carriers for enhanced diabetic wound-healing therapy. Int J Nanomedicine. 2019;14:5449–75. https://doi.org/10.2147/IJN.S213883.

Article  CAS  PubMed  PubMed Central  Google Scholar 

P. Kesharwani, V. Mishra, and N. K. Jain, “Validating the anticancer potential of carbon nanotube-based therapeutics through cell line testing,” Drug Discov. Today, vol. 20, no. 9, 2015, https://doi.org/10.1016/j.drudis.2015.05.004.

P. Kesharwani et al., “Gold nanoparticles and gold nanorods in the landscape of cancer therapy,” Mol. Cancer. 2023 221, vol. 22, no. 1, pp. 1–31, Jun. 2023, https://doi.org/10.1186/S12943-023-01798-8.

Y. Yao et al., “Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance,” Aug. 2020, Frontiers Media S.A. https://doi.org/10.3389/fmolb.2020.00193.

L. A. Jha, B. Kumar, S. K. Jha, and K. R. Paudel, “Futuristic senolytic drug incorporated nanomedicine therapy to treat osteoarthritis,” Nanomed., vol. 19, no. 10, Apr. 2024, https://doi.org/10.2217/NNM-2023-0348.

Imran M, et al. ‘Nanodecoys’ - Future of drug delivery by encapsulating nanoparticles in natural cell membranes. Int J Pharm. 2022;621:121790. https://doi.org/10.1016/J.IJPHARM.2022.121790.

Article  CAS  PubMed  Google Scholar 

Jha SK, et al. A Comprehensive review on Pharmacokinetic Studies of Vaccines: Impact of delivery route, carrier-and its modulation on immune response. Environ Res. 2023;236:116823. https://doi.org/10.1016/J.ENVRES.2023.116823.

Article  CAS  PubMed  Google Scholar 

Hasan N, et al. Advanced targeted drug delivery by bioengineered white blood cell-membrane camouflaged nanoparticulate delivery nanostructures. Environ Res. 2023;238:117007. https://doi.org/10.1016/J.ENVRES.2023.117007.

Article  CAS  PubMed  Google Scholar 

S. K. Jha et al., “Cellular Senescence in Lung Cancer: Molecular Mechanisms and Therapeutic Interventions,” Ageing Res. Rev., p. 102315, Apr. 2024, https://doi.org/10.1016/J.ARR.2024.102315.

Mukherjee S, Mukherjee S, Abourehab MAS, Sahebkar A, Kesharwani P. Exploring dendrimer-based drug delivery systems and their potential applications in cancer immunotherapy. Eur Polym J. 2022;177:111471. https://doi.org/10.1016/J.EURPOLYMJ.2022.111471.

Article  CAS  Google Scholar 

Sheikh A, Md S, Kesharwani P. Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer. Biomed Pharmacother. 2022;146:112530. https://doi.org/10.1016/J.BIOPHA.2021.112530.

Article  CAS  PubMed  Google Scholar 

Singh R, Shitiz K, Singh A. Chitin and chitosan: biopolymers for wound management. Int Wound J. 2017;14(6):1276–89. https://doi.org/10.1111/IWJ.12797.

Article  PubMed  PubMed Central  Google Scholar 

Sheikh A, Md S, Alhakamy NA, Kesharwani P. Recent development of aptamer conjugated chitosan nanoparticles as cancer therapeutics. Int J Pharm. 2022;620:121751. https://doi.org/10.1016/J.IJPHARM.2022.121751.

Article  CAS  PubMed  Google Scholar 

V. S. Madamsetty et al., “Chitosan: A versatile bio-platform for breast cancer theranostics,” J Control Release Off J Control Release Soc., vol. 341, pp. 733–752, Jan. 2021, https://doi.org/10.1016/J.JCONREL.2021.12.012.

Rathore P, Mahor A, Jain S, Haque A, Kesharwani P. Formulation development,: In vitro and in vivo evaluation of chitosan engineered nanoparticles for ocular delivery of insulin. RSC Adv. 2020;10(71):43629–39. https://doi.org/10.1039/d0ra07640f.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dongsar TT, Dongsar TS, Gupta N, Almalki WH, Sahebkar A, Kesharwani P. Emerging potential of 5-Fluorouracil-loaded chitosan nanoparticles in cancer therapy. J Drug Deliv Sci Technol. 2023;82:104371. https://doi.org/10.1016/J.JDDST.2023.104371.

Article  CAS  Google Scholar 

P. Kesharwani et al., “Itraconazole and Difluorinated-Curcumin Containing Chitosan Nanoparticle Loaded Hydrogel for Amelioration of Onychomycosis,” Biomim. 2022 Vol 7 Page 206, vol. 7, no. 4, p. 206, Nov. 2022, https://doi.org/10.3390/BIOMIMETICS7040206.

Sheikh A, et al. Hyaluronic acid engineered gallic acid embedded chitosan nanoparticle as an effective delivery system for treatment of psoriasis. Environ Res. 2023;238:117086. https://doi.org/10.1016/J.ENVRES.2023.117086.

Article  CAS  PubMed  Google Scholar 

Rodrigues S, Dionísio M, López CR, Grenha A. Biocompatibility of Chitosan Carriers with Application in Drug Delivery. J Funct Biomater. 2012;3(3):615–41. https://doi.org/10.3390/jfb3030615.

Article  CAS  PubMed  PubMed Central  Google Scholar 

N. Desai et al., “Chitosan: A Potential Biopolymer in Drug Delivery and Biomedical Applications,” Pharm. 2023 Vol 15 Page 1313, vol. 15, no. 4, p. 1313, Apr. 2023, https://doi.org/10.3390/PHARMACEUTICS15041313.

Xu J, et al. Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis. Acta Biomater. 2017;48:247–57. https://doi.org/10.1016/J.ACTBIO.2016.10.026.

Article  CAS  PubMed  Google Scholar 

Pavoni JMF, Luchese CL, Tessaro IC. Impact of acid type for chitosan dissolution on the characteristics and biodegradability of cornstarch/chitosan based films. Int J Biol Macromol. 2019;138:693–703. https://doi.org/10.1016/J.IJBIOMAC.2019.07.089.

Article  CAS  PubMed  Google Scholar 

C. P. Jiménez-Gómez, J. A. Cecilia, M. Guidotti, and R. Soengas, “Chitosan: A Natural Biopolymer with a Wide and Varied Range of Applications,” Mol. 2020 Vol 25 Page 3981, vol. 25, no. 17, p. 3981, Sep. 2020, https://doi.org/10.3390/MOLECULES25173981.